876589-13-8 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloromethyl-pyrrolidine-1-carboxylic acid tert-buty酯 is used as an intermediate in the synthesis of various pharmaceuticals for its ability to undergo a wide range of chemical transformations, contributing to the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Chloromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester serves as an intermediate in the synthesis of various agrochemicals, playing a crucial role in the development of new pesticides and other agricultural chemicals.
Used in Organic Synthesis:
3-Chloromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a building block in organic synthesis due to its versatile reactivity, enabling the creation of a variety of complex organic compounds for different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 876589-13-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,5,8 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 876589-13:
(8*8)+(7*7)+(6*6)+(5*5)+(4*8)+(3*9)+(2*1)+(1*3)=238
238 % 10 = 8
So 876589-13-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H18ClNO2/c1-10(2,3)14-9(13)12-5-4-8(6-11)7-12/h8H,4-7H2,1-3H3
876589-13-8Relevant academic research and scientific papers
Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents
Miller, John F.,Turner, Elizabeth M.,Gudmundsson, Kristjan S.,Jenkinson, Stephen,Spaltenstein, Andrew,Thomson, Michael,Wheelan, Pat
experimental part, p. 2125 - 2128 (2010/06/13)
The lead optimization of a series of N-substituted benzimidazole CXCR4 antagonists is described. Side chain modifications and stereochemical optimization led to substantial improvements in potency and protein shift to afford compounds with low nanomolar a
CHEMICAL COMPOUNDS
-
Page/Page column 65, (2010/10/20)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
